Redx Pharma Stock Price, News & Analysis (LON:REDX)

GBX 14.25 +0.25 (+1.79 %)
(As of 02/21/2018 02:27 PM ET)
Previous CloseGBX 14.25
Today's RangeGBX 13.65 - GBX 14.25
52-Week RangeGBX 13.25 - GBX 43
Volume65,391 shs
Average Volume50,252 shs
Market Capitalization£13.43 million
P/E Ratio-1,425.00
Dividend YieldN/A
BetaN/A

About Redx Pharma (LON:REDX)

Redx Pharma logoRedx Pharma Plc, formerly Redx Pharma Ltd, is engaged in drug discovery, pre-clinical development and licensing. The Company is engaged in drug discovery across cancer, infection and autoimmune diseases. The Company has over two programs in its oncology research activity, Smoothened Hedgehog (SMO) and Bruton's Tyrosine Kinase (BTK), which has reached candidate nomination stage. The Company's oncology research activity also include Porcupine program, Colony Stimulating Factor-1 receptor (CSF-1) program, Indoleamine-pyrrole 2,3-dioxygenase (IDO) inhibitor and Pan-Raf inhibitor. The Company's anti-infective candidate compound is an antibiotic that the Company has developed to treat a range of Gram-positive bacterial infections, including resistant strains, such as Methicillin-Resistant Staphylococcus Aureus (MRSA). Its product candidate, RDX003, is a class of antibiotic acting through the type II bacterial topoisomerases. It is also evaluating BTK inhibitor for immunological disorders.

Receive REDX News and Ratings via Email

Sign-up to receive the latest news and ratings for REDX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorHealthcare
SymbolLON:REDX
CUSIPN/A
Phone+44-151-7064747

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-1425
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.01)
Net IncomeN/A
Net Margins40.10%
Return on Equity294.97%
Return on Assets123.97%

Miscellaneous

EmployeesN/A
Outstanding Shares126,480,000

Redx Pharma (LON:REDX) Frequently Asked Questions

What is Redx Pharma's stock symbol?

Redx Pharma trades on the London Stock Exchange (LON) under the ticker symbol "REDX."

Who are some of Redx Pharma's key competitors?

Who are Redx Pharma's key executives?

Redx Pharma's management team includes the folowing people:

  • Neil David Murray, Chief Executive Officer, Co-Founder, Executive Director
  • Peter Jackson, Co-Founder, Non-Executive Director
  • Derek Lindsay, Chief Operating Officer
  • Simon William Thorn, Company Secretary
  • Iain Ross, Non-Executive Chairman of the Board
  • Bernhard Jurgen Kirschbaum, Non-Executive Director (Age 57)
  • Peter McPartland, Non-Executive Director
  • Norman James Molyneux, Non-Executive Director

How do I buy Redx Pharma stock?

Shares of Redx Pharma and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Redx Pharma's stock price today?

One share of Redx Pharma stock can currently be purchased for approximately GBX 14.25.

How big of a company is Redx Pharma?

Redx Pharma has a market capitalization of £13.43 million.

How can I contact Redx Pharma?

Redx Pharma's mailing address is Block 33, Mereside,, Alderley Park, MACCLESFIELD, SK10 4TG, United Kingdom. The company can be reached via phone at +44-151-7064747.


MarketBeat Community Rating for Redx Pharma (REDX)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  121
MarketBeat's community ratings are surveys of what our community members think about Redx Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Redx Pharma (LON:REDX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A

Redx Pharma (LON:REDX) Consensus Price Target History

Price Target History for Redx Pharma (LON:REDX)

Redx Pharma (LON:REDX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/24/2016Shore CapitalReiterated Ratinghouse stockView Rating Details
(Data available from 2/21/2016 forward)

Earnings

Earnings History for Redx Pharma (LON:REDX)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Redx Pharma (LON:REDX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Redx Pharma (LON:REDX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Redx Pharma (LON REDX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Redx Pharma (LON:REDX)

Redx Pharma (LON REDX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2017Iain RossInsiderBuy102,000GBX 21£21,420
11/14/2017Iain RossInsiderBuy348,000GBX 18£62,640
11/6/2015Molyneux,NormanInsiderBuy6,250GBX 80£5,000
11/5/2015Molyneux,NormanInsiderBuy6,250GBX 80£5,000
(Data available from 1/1/2013 forward)

Headlines

Redx Pharma (LON REDX) News Headlines

Source:
DateHeadline
BRIEF-Redx Pharma Says First Patient Dosed In Phase 1/2a Trial Of RXC004BRIEF-Redx Pharma Says First Patient Dosed In Phase 1/2a Trial Of RXC004
www.reuters.com - February 6 at 8:22 AM
Redx Pharma Doses First Patient As RXC004 Phase 1/2a Study BeginsRedx Pharma Doses First Patient As RXC004 Phase 1/2a Study Begins
www.morningstar.co.uk - February 6 at 8:22 AM
What Should We Expect From Redx Pharma Plc’s (LON:REDX) Earnings In The Years Ahead?What Should We Expect From Redx Pharma Plc’s (LON:REDX) Earnings In The Years Ahead?
finance.yahoo.com - January 29 at 8:26 AM
Redx Pharma Appoints Andrew Saunders As Chief Medical OfficerRedx Pharma Appoints Andrew Saunders As Chief Medical Officer
www.morningstar.co.uk - January 23 at 9:14 AM
DIRECTOR DEALINGS SUMMARY: CRH Non-Executive Director Sells Shares - London South East (blog)DIRECTOR DEALINGS SUMMARY: CRH Non-Executive Director Sells Shares - London South East (blog)
www.lse.co.uk - December 29 at 11:35 AM
Iain Ross Acquires 102,000 Shares of Redx Pharma PLC (REDX) StockIain Ross Acquires 102,000 Shares of Redx Pharma PLC (REDX) Stock
www.americanbankingnews.com - December 28 at 12:06 AM
DIRECTOR DEALINGS: Redx Pharma Chairman Buys 102,000 SharesDIRECTOR DEALINGS: Redx Pharma Chairman Buys 102,000 Shares
www.morningstar.co.uk - December 27 at 4:30 PM
Corporate Update - London South East (blog)Corporate Update - London South East (blog)
www.lse.co.uk - December 22 at 5:56 PM
What Investors Should Know About Redx Pharma Plc’s (LON:REDX) Financial StrengthWhat Investors Should Know About Redx Pharma Plc’s (LON:REDX) Financial Strength
finance.yahoo.com - December 18 at 11:17 AM
Have Investors Already Priced In Redx Pharma Plc’s (AIM:REDX) Growth?Have Investors Already Priced In Redx Pharma Plc’s (AIM:REDX) Growth?
finance.yahoo.com - December 8 at 4:06 PM
Iain Ross Buys 348,000 Shares of Redx Pharma PLC (REDX) StockIain Ross Buys 348,000 Shares of Redx Pharma PLC (REDX) Stock
www.americanbankingnews.com - November 14 at 7:41 AM
[$$] Redx resurrected after near-death experience[$$] Redx resurrected after near-death experience
finance.yahoo.com - November 12 at 12:15 PM
[$$] Redx restarts trading on return from administration[$$] Redx restarts trading on return from administration
finance.yahoo.com - November 7 at 9:32 AM
Update on Application to the High Court - London South East (blog)Update on Application to the High Court - London South East (blog)
www.lse.co.uk - October 27 at 11:49 PM
BRIEF-Redx Pharma administrators seek to rescure company as going concernsBRIEF-Redx Pharma administrators seek to rescure company as going concerns
www.reuters.com - October 13 at 8:39 AM
Should You Have Redx Pharma Plc’s (AIM:REDX) In Your Portfolio?Should You Have Redx Pharma Plc’s (AIM:REDX) In Your Portfolio?
finance.yahoo.com - October 3 at 11:30 AM
Redx to present new scientific data at ESMO 2017 - London South East (registration) (blog)Redx to present new scientific data at ESMO 2017 - London South East (registration) (blog)
www.lse.co.uk - September 1 at 7:58 AM
[$$] Danger of getting hooked on public cash transfusions[$$] Danger of getting hooked on public cash transfusions
finance.yahoo.com - August 28 at 6:03 AM
Featured Company News - Loxo Oncology Acquires Reversible BTK Inhibitor Program from UK Biotech Firm Redx PharmaFeatured Company News - Loxo Oncology Acquires Reversible BTK Inhibitor Program from UK Biotech Firm Redx Pharma
www.nasdaq.com - August 2 at 8:55 PM
PRESS DIGEST- British Business - Aug 1 - Reuters - ReutersPRESS DIGEST- British Business - Aug 1 - Reuters - Reuters
www.reuters.com - August 1 at 5:32 AM
Redx Pharma In Talks With Administrators To Rescue CompanyRedx Pharma In Talks With Administrators To Rescue Company
www.morningstar.co.uk - June 22 at 10:17 AM
Redx Request AIM Suspension Of Shares With Administrators Ap - London South East (registration) (blog)Redx Request AIM Suspension Of Shares With Administrators Ap - London South East (registration) (blog)
www.lse.co.uk - May 26 at 6:27 AM
Bone Metastasis Therapeutic Pipeline Review H1 2017 Research Report Now Available at RnRMarketResearch.comBone Metastasis Therapeutic Pipeline Review H1 2017 Research Report Now Available at RnRMarketResearch.com
www.bizjournals.com - May 24 at 7:54 PM
Redx Request AIM Suspension Of Shares With Administrators Appointed (ALLISS)Redx Request AIM Suspension Of Shares With Administrators Appointed (ALLISS)
www.morningstar.co.uk - May 24 at 7:54 PM
Redx Pharma Expects Further Progress As Interim Loss Widens - London South East (registration) (blog)Redx Pharma Expects Further Progress As Interim Loss Widens - London South East (registration) (blog)
www.lse.co.uk - May 18 at 9:54 AM
Redx Pharma Expects Further Progress As Interim Loss WidensRedx Pharma Expects Further Progress As Interim Loss Widens
www.morningstar.co.uk - May 17 at 8:01 AM
BRIEF-Redx Pharma appoints Iain Ross as chairman of board of directorsBRIEF-Redx Pharma appoints Iain Ross as chairman of board of directors
www.reuters.com - April 20 at 8:37 AM
Full Year 2016 Redx Pharma PLC Earnings Release - Before Market OpenFull Year 2016 Redx Pharma PLC Earnings Release - Before Market Open
biz.yahoo.com - March 21 at 10:37 AM
Seneca Partners Becomes Largest Shareholder In Redx Pharma (ALLISS)Seneca Partners Becomes Largest Shareholder In Redx Pharma (ALLISS)
www.morningstar.co.uk - March 8 at 8:48 AM
[$$] Small-cap focus: UK regions[$$] Small-cap focus: UK regions
www.ft.com - February 17 at 7:58 PM
Redx Pharma unveils plans to raise up to £14.9mln to accelerate drug development plansRedx Pharma unveils plans to raise up to £14.9mln to accelerate drug development plans
www.msn.com - February 10 at 10:23 PM
Redx Pharma Raises GBP7.2 Million From Share Placing (ALLISS)Redx Pharma Raises GBP7.2 Million From Share Placing (ALLISS)
www.morningstar.co.uk - February 10 at 10:23 PM
Redx Pharma Plans To Raise Up To GBP14.9M In Share Placing, Open Offer (ALLISS) - London South East (registration) (blog)Redx Pharma Plans To Raise Up To GBP14.9M In Share Placing, Open Offer (ALLISS) - London South East (registration) (blog)
www.lse.co.uk - February 10 at 4:08 AM
Redx Pharma Plans To Raise Up To GBP14.9M In Share Placing, Open Offer (ALLISS)Redx Pharma Plans To Raise Up To GBP14.9M In Share Placing, Open Offer (ALLISS)
www.morningstar.co.uk - February 8 at 10:42 PM
Verseon Present At US Haematol - London South East (registration) (blog)Verseon Present At US Haematol - London South East (registration) (blog)
www.lse.co.uk - December 9 at 12:58 AM
Wednesday preview: UK jobs data, US inflation figuresWednesday preview: UK jobs data, US inflation figures
uk.finance.yahoo.com - August 24 at 10:08 AM

SEC Filings

Redx Pharma (LON:REDX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Redx Pharma (LON REDX) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.